Immunizations Flashcards
Active immunity
Production of antibodies in response to an antigen. Active immunity can result from exposure to a pathogen or through immunization that occurs with exposure to either a toxin or toxoid
Passive immunity
Antibodies obtained from an outside source. Examples of passive immunity are maternal-fetal transfer of antibodies and the administration of antibodies such as IVIG
Immunogenicity
The ability of a particular substance, which is called the antigen, to provoke an immune response
Efficacy
How well a vaccine protects against a dz state. A vaccine if effective if there is a reduction in dz cases resulting from the administration of the vaccine
Herd immunity
The protection of non-vaccinated ppl that results from those who get the immunizations
General principles of vaccines
The closer a vaccine is to the dz-causing form of the organism, the better the immune response of the vaccine
All vaccines can be administered at the same visit as all other vaccines
If not given at the same visit, live parenteral and intranasal vaccines should be separated by at least four weeks
Increasing the interval between doses of a multidose vaccine does not diminish the effectiveness of the vaccine
Vaccine doses cannot be divided into partial doses
The only universal absolute contraindication is hx of anaphylactic rxn to a vaccine
False contraindications to vaccination
Mild illness Antimicrobial therapy Dz exposure or convalescence Breastfeeding Preterm birth Allergy to products not present in vaccine or allergy that is not anaphylactic FHx of adverse events Tb skin testing Multiple vaccines
Example of a toxoid vaccine
TdaP
Example of a polysaccharide vaccine
Typhoid polysaccharide vaccine
Old meningococcal
23-valent pneumococcal
Example of a conjugated vaccine
Hib
Meningococcal polysaccharide vaccine
Example of a whole bacterial vaccine
Old pertussis
Typhoid vaccine inactivated
Example of a whole virion vaccine
IPV
Whole influenza vaccine
Japanese encephalitis
Both rabies vaccines
Example of a split-virion vaccine
Split-virion influenza
Hep A
Example of a recombinant vaccine
Hep B
HPV
What are the two kinds of live viral vaccines?
Enteral/intranasal
Parenteral
Example of an enteral/intranasal vaccine
Live-attenuated influenza
Rotavirus (OPV)
Example of a parenteral live vaccine
Varicella zoster
MMR
Yellow fever
Example of live bacterial vaccine
Typhoid Ty21a
BCG
Details of Hep B virus
Viral hep with long-term fatality rate approaching 100% after congenital infection Recombinant vaccine (HbsAg) starting at birth Recommended for all infants starting at less than or equal to 12 hours of age 3 doses at 0, 1, 6 mos Antibody wanes over years, but auto-boost results in prolonged efficacy
Details of rotavirus
Viral agent of severe gastroenteritis in children <2 yo
Live pentavalent bovine/human reassortant vaccine licensed for age 6-32 wks
3 doses at 2, 4, and 6 mos protect for at least 2 seasons
Details of TDap
Tetanus risk related to hygiene, vaccine status (no herd immunity)
Diphtheria and pertussis risks depend on exposure (herd immunity occurs)
Trivalent combined toxoids, available in several combinations
-D= high-dose diphtheria (children <7 yo)
-d= low-dose diphtheria (7 and older)
-aP or ap= acellular pertussis (all current formulations)
Give DTaP at 2, 4, 6, and 18 mos, 4-6 yrs, then TdaP every 10 yrs starting at 11.
Details of hib virus
Until the advent of universal immunization, the MC bacterial cause of meningitis in infants and children <5 yo
Conjugated polysaccharide vaccine cannot be given to infants < 6 wks old
Natural exposure results in near-universal immunity by age 5
Routinely given at 2, 4, (6), 12-15 mos
Details of pneumococcus vaccine and virus
MC bacterial agent of meningitis and bacteremia in children exposed to the community (>6 wks old)
MC bacterial agent of otitis media; also a common agent of pneumonia
Two licensed vaccines:
7-valent conjugated polysaccharide for age 6 wks to 4 yrs (PCV-7)
23-valent polysaccharide for age 5 and older (PPV)
PCV-7 is routinely given at 2, 4, 6, 12-15 mos
Details of polio virus and vaccine
Currently virus does not circulate in the western hemisphere
Immunization prevents reestablishment and protects travelers
IPV is the only vaccine used in the US: trivalent, inactivated, whole-viron vaccine
Routinely given at 2, 4, and 6-18 mos, 4-6 yrs
May require boosting for high-risk adult travelers